HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An acquired bullous dermatosis due to an autoimmune reaction against uncein.

Abstract
A 59-year-old male showed acquired, mechanically induced, scarring blisters on the fingers, toes, scalp and abdomen, as well as in the oral cavity. Ultrastructural and immunohistochemical examination of the bullae revealed junctional epidermal-dermal separation and IgG deposits in the lamina lucida of the basement membrane zone (BMZ), where the reactivity of the 19-DEJ-1 monoclonal antibody was decreased. Anti-BMZ autoantibodies detected in his serum were reactive to the lower lamina lucida region of normal human skin. SDS-PAGE of affinity purified antigens from human keratinocytes with IgG from the patient's serum revealed three polypeptide bands at 165, 135 and 100 kDa, in reduced condition. The indirect immunofluorescence test of his serum was negative on skin cryosections from patients with lethal junctional epidermolysis bullosa. Pretreatment of normal human skin sections with the patient's serum, blocked the binding of 19-DEJ-1 monoclonal antibody but not that of the GB3 monoclonal antibody. This case is considered to be an acquired autoimmune bullous dermatosis due to an autoantibody reaction against uncein (19-DEJ-1 antigen), a component of anchoring filaments.
AuthorsY Horiguchi, M Ueda, H Shimizu, T Tanaka, N Matsuyoshi, A Utani, K Ikai, T Nishikawa, S Imamura
JournalThe British journal of dermatology (Br J Dermatol) Vol. 134 Issue 5 Pg. 934-8 (May 1996) ISSN: 0007-0963 [Print] England
PMID8736340 (Publication Type: Case Reports, Journal Article)
Chemical References
  • 19-DEJ-1 antigen
  • Antigens
Topics
  • Antigens (immunology)
  • Autoimmune Diseases (immunology, pathology)
  • Fluorescent Antibody Technique
  • Humans
  • Male
  • Middle Aged
  • Skin (immunology, ultrastructure)
  • Skin Diseases, Vesiculobullous (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: